노바렉스

194700KOSDAQ기타 식품 제조업

68.3 / 100

Reference Date: 2026-06-10

Financial Score30.0 / 40

News Sentiment21.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but PBR raises overvaluation concerns. Slightly down 1.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

NovaLex, established in 2008, specializes in manufacturing and exporting health functional foods, producing products such as supercritical omega-3 and VitaPack programs. The company holds 47 of South Korea's largest individually certified raw materials and leads market trends through ODM/OEM business. It manages financial risks to maintain financial stability.

Number of Employees

505people

Average Salary

58.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

7.25Industry Average 13.216.5Point

Lower than industry avg (good)

PBR

1.04Industry Average 0.561.0Point

1.9x industry avg (risky)

ROE

15.15Industry Average 2.727.0Point

5.6x industry avg (excellent)

Debt Ratio

4.21Industry Average 11.916.5Point

Half of industry avg (excellent)

Trend 2023~20259.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲38.3% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 12.7% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
노바렉스, 지난해 건기식 생산액 1위…"다품종 연구+제조 역량 효과"
노바렉스가 지난해 국내 건강기능식품 시장에서 생산액 1위를 달성하며 성장을 입증했다.
Positive
[클릭 e종목]"노바렉스, 국내외 실적 호조…목표가↑"
DS투자증권의 노바렉스 실적 호조에 따른 목표 주가 상향으로 긍정적인 시장 반응 예상.
Positive
노바렉스, 1Q 영업익 141억원…전년比 68%↑ "글로벌 성장 본격화...
노바렉스의 1분기 실적이 전년 대비 매출과 영업이익 모두 크게 증가하여 긍정적인 시장 반응을 보임.

Detailed Momentum

52-week position3.0Point

52w lower range (25%)

Current 14,500Won52-week high 22,00052-week low 11,940

1-month return3.0Point

1m -1.02% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral분기보고서 (2026.03)2026-05-15
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-15
Neutral주식등의대량보유상황보고서(일반)2026-05-15